Hadassah Medical Center
Jerusalem, 91120, Israel
NCT Number: NCT03088865
Implementation of the initial specimen diversion technique, in which the first milliliter of the venipuncture sample is not injected into the culture bottle, led to a significant reduction in blood culture contamination rates. This technique is based on the assumption that the skin plug aspirated during venipuncture is a major source of contaminating bacteria. One such diversion method is aspirating the first blood volume into a blood collection tube. It has, however, been suggested that regular blood collection tubes carry contaminants from the tube's stopper into the blood cultures drawn afterwards, thereby increasing contamination rates. The aim of this trial is to examine the effect of aspirating the first blood volume into a regular blood collection tube on blood culture contamination rate.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Jerusalem, 91120, Israel
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
order of blood drawing
Time frame: 7 days
A blood culture contamination is defined as growth in a single set of coagulase-negative Staphylococcus, Micrococcus, Viridans group Streptococcus, Propionibacterium acne, Corynebacterium sp (diphtheroids) or Bacillus sp.
Hadassah Medical Organization
Other
Evaluation of an Internal Hospital Practice: The Effect of Altered Sampling Protocol on Blood Culture Contamination Rates: An Open, Randomized, Prospective Study
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT01520597
Bacterial Infections, Bacterial Infections and Mycoses
Paris, France
View Trial DetailsNCT05045963
Hematologic Diseases, Hematologic Neoplasms
Houston, Texas, United States
View Trial DetailsNCT05040503
Infections, Inflammation
Dijon, France
View Trial DetailsNCT05358912
Cardiovascular Diseases, Compartment Syndromes
Izmir, Karabağlar, Turkey (Türkiye)
View Trial Details